COVID-19 Monoclonal Antibody Infusion


PDF Version

TO:  Hospitals


As Alabama Medicaid continues to monitor the COVID-19 national emergency in Alabama, Medicaid is adding the following procedure codes for coverage:



Effective date


Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring



Intravenous infusion, casirivimab and imdevimab includes infusion and post administration monitoring


Providers may submit claims for dates of service on or after the effective dates for each procedure code as listed above.


Providers may find the reimbursement rates for the COVID-19 testing procedure codes on Medicaid’s website at by selecting Fee Schedules under the Providers tab.


As a reminder, providers must deliver services within their scope of practice and have the proper certification and licensure to perform these tests. 


During the COVID-19 emergency, it is important to file claims as quickly as possible to ensure payment from Medicaid to Medicaid providers close to the date of service. The Centers for Medicare and Medicaid Services (CMS) has increased the federal matching percentage for the emergency time frame, but states can only receive the increased match on claims paid during the emergency. Providers should include appropriate COVID-19 diagnosis code(s) on claims submitted to help with tracking of COVID-19.


For questions, please visit the Medicaid website at, or call the Medicaid Fiscal Agent at 1-800-688-7989.

Contacts:, or


The Current Procedural Terminology (CPT) and Current Dental Terminology (CDT) codes descriptors, and other data are copyright © 2021 American Medical Association and © 2021 American Dental Association (or such other date publication of CPT and CDT). All rights reserved. Applicable FARS/DFARS apply.